Speakers Across
CMC Strategies • CDMO Market Trends • GLP-1 & Biosimilar Innovations • Manufacturing & AI Optimization
Venture Capital & Investment Forecasts • Drug Product Development • Peptide Therapeutics • Sustainability & Supply Chain Management
Robert Geiger, Ph.D
Senior Director of Business Development
Juizhou Pharmaceutical Co
Keith Dodson
Executive Director Business Development
Porton Pharma Solutions
Pep Gubau
CEO
Aizon
Brian Scanlan
Operating Partner, Life Sciences
Edgewater Capital
Lisa Studnicki
Co-Founder, COO
GL Chemtec
Ray Forslund
Senior VP, CMC
SynerG Consulting
Dino Dedic
Senior Managing Director
Guggenheim Securities
Scott Waldman
Managing Member
Waldman Growth Strategies
Deb Minor
President
Drug Discovery Alliances
Jim Bruno
Principal
Chemical and Pharmaceutical Solutions
Sean Bradley
Vice President of Business Development
GL Chemtec International Ltd.
Malcolm Rosenthal
Consultant
Phlow Corp
Robert Miller
Consultant
AbbVie (Retired) Growth Strategies
George Regan
Consultant
Pfizer (Retired)
Nick Bell
Managing Director, Pharma Services
Baird Global Healthcare Investment Banking
Chris Conway
CEO
BioXcell
Ramesh Subramanian
Global CEO
PI Health Sciences
Steve Beagle
Principal
Pharmeagle Partners Consulting
Victor Li
Head of BD for North American Region
Apeloa Pharma
Dennis Murachanian
Principal
818 Pharmaceutical Consulting
Roger Laforce
Managing Director
DORRA EUROPE
Brian Treco
Vice President, Business Development
Agno Pharma
Oliver Hughes
Managing Consultant
Harris & Co Executive Search
Francis Gibson
Executive Search Consultant
Harris & Co Executive Search
Stefan Loren, Ph.D.
Managing Director, Healthcare Investment Banking
Oppenheimer
Hugh Huang
Vice President, Drug Product R&D
J-STAR Research, Inc.
Ray Sison
Managing Partner
SCxCMC LLC
Ronald Vladyka
Director, Drug Product GMP Operations
J-STAR Research, Inc.
Trishul Shah
Director Global Sales and Marketing
PolyPeptide Group
John Phipps
Vice President of Clinical Pipeline Development
CPC Scientific
Colin Smith
Pharma Innovation Leader
Aurorium
Rob Camerer
CEO
Global Pharma Partners
Tim Nieters
Senior VP of Strategic Portfolio Development
CPC Scientific
Nigel Walker
CEO
That’s Nice
Ankit Aggarwal
VP Healthcare Investment Banking
JP Morgan
Jonathan Collins
Vice President Business Development
CEM Corporation
Ray Alsko
Director of Business Development
Sterling Pharma Solutions
Brien McDonough
Director of Business Development
CEM AnaSpec
Mimoun Ayoub
Senior VP, Global Head Sales & Key Accounts
Corden Pharma
Matteo Villain
Vice President & Global Peptides Technical Lead
Piramal Pharma Solutions
Tangqing Li
SVP
Sinopep-Allsino Biopharmaceutical Co.
Robert Bloder
Chief Business Officer
Ascendia Pharmaceuticals
Tushar Nuwal
CEO
Ligandal
TJ Higley
CEO
Microsize
Ken Drew
Vice President
Flamma USA
Masha Kononov
National Director of Business Development
Ingenza Ltd
Anil Kane
Global Head of Technical & Scientific Affairs
ThermoFisher Scientific
Tom Hunter
Associate Director, Process Development
Millipore Sigma
Gangli Gong
Senior Director
STA Pharmaceutical
Derron Stark
Partner
EY Parthenon
Brian Gavin
Senior Director
EY Parthenon
Louise Duffy
CTO/CQO
Abzena
Dom Hebrault
Associate Director Process Engineering
Veranova
Xingren Jiang
Business Specialist
Jiuzhou Pharma
Simon Hickling
VP – CDMO Business Development
Phlow
Luca Dalla Torre
General Counsel
Siegfried Holding AG
Mike Spangler
Principal
Spangler Consulting
James Kanter
Principal
K2 CMC
Jean-Jacques (John) Mondoloni
Managing Partner
Wombat Capital
Johnny Montoya
Tax Principal, Transaction Advisory Services
BDO
Jon Moore
Director, Transaction Advisory Services
BDO